Literature DB >> 26129969

Core protein: A pleiotropic keystone in the HBV lifecycle.

Adam Zlotnick1, Balasubramanian Venkatakrishnan2, Zhenning Tan3, Eric Lewellyn3, William Turner3, Samson Francis4.   

Abstract

Hepatitis B Virus (HBV) is a small virus whose genome has only four open reading frames. We argue that the simplicity of the virion correlates with a complexity of functions for viral proteins. We focus on the HBV core protein (Cp), a small (183 residue) protein that self-assembles to form the viral capsid. However, its functions are a little more complicated than that. In an infected cell Cp modulates almost every step of the viral lifecycle. Cp is bound to nuclear viral DNA and affects its epigenetics. Cp correlates with RNA specificity. Cp assembles specifically on a reverse transcriptase-viral RNA complex or, apparently, nothing at all. Indeed Cp has been one of the model systems for investigation of virus self-assembly. Cp participates in regulation of reverse transcription. Cp signals completion of reverse transcription to support virus secretion. Cp carries both nuclear localization signals and HBV surface antigen (HBsAg) binding sites; both of these functions appear to be regulated by contents of the capsid. Cp can be targeted by antivirals - while self-assembly is the most accessible of Cp activities, we argue that it makes sense to engage the broader spectrum of Cp function. This article forms part of a symposium in Antiviral Research on "From the discovery of the Australia antigen to the development of new curative therapies for hepatitis B: an unfinished story."
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral therapy; Capsid; Hepatitis B Virus; Self-assembly

Mesh:

Substances:

Year:  2015        PMID: 26129969      PMCID: PMC4537649          DOI: 10.1016/j.antiviral.2015.06.020

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  167 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.

Authors:  Xue-Yan Wang; Zhen-Man Wei; Guo-Yi Wu; Jiang-Hua Wang; Ying-Jun Zhang; Jing Li; Heng-Hui Zhang; Xing-Wang Xie; Xian Wang; Zhao-He Wang; Lai Wei; Yu Wang; Hong-Song Chen
Journal:  Antivir Ther       Date:  2012-06-06

Review 3.  How does your virus grow? Understanding and interfering with virus assembly.

Authors:  Adam Zlotnick; Stephen J Stray
Journal:  Trends Biotechnol       Date:  2003-12       Impact factor: 19.536

Review 4.  Diverse roles of hepatitis B virus in liver cancer.

Authors:  Guillaume Fallot; Christine Neuveut; Marie-Annick Buendia
Journal:  Curr Opin Virol       Date:  2012-06-19       Impact factor: 7.090

5.  Distinguishing reversible from irreversible virus capsid assembly.

Authors:  Adam Zlotnick
Journal:  J Mol Biol       Date:  2006-11-11       Impact factor: 5.469

6.  Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity.

Authors:  J Zachary Porterfield; Mary Savari Dhason; Daniel D Loeb; Michael Nassal; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

Authors:  Julie Lucifora; Silke Arzberger; David Durantel; Laura Belloni; Michel Strubin; Massimo Levrero; Fabien Zoulim; Olivier Hantz; Ulrike Protzer
Journal:  J Hepatol       Date:  2011-03-02       Impact factor: 25.083

8.  Utilization of host SR protein kinases and RNA-splicing machinery during viral replication.

Authors:  Takeshi Fukuhara; Takamitsu Hosoya; Saki Shimizu; Kengo Sumi; Takako Oshiro; Yoshiyuki Yoshinaka; Masaaki Suzuki; Naoki Yamamoto; Leonore A Herzenberg; Leonard A Herzenberg; Masatoshi Hagiwara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-13       Impact factor: 11.205

9.  Morphological irregularities in Dane particle cores.

Authors:  L M Stannard; M Hodgkiss
Journal:  J Gen Virol       Date:  1979-11       Impact factor: 3.891

10.  Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs.

Authors:  W Liao; J H Ou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more
  84 in total

1.  Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.

Authors:  Xi Yang; Hongfeng Li; Huahui Sun; Hongxia Fan; Yaqi Hu; Min Liu; Xin Li; Hua Tang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Characterization of Virus Capsids and Their Assembly Intermediates by Multicycle Resistive-Pulse Sensing with Four Pores in Series.

Authors:  Jinsheng Zhou; Panagiotis Kondylis; Daniel G Haywood; Zachary D Harms; Lye Siang Lee; Adam Zlotnick; Stephen C Jacobson
Journal:  Anal Chem       Date:  2018-05-29       Impact factor: 6.986

3.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

4.  Competition between Normative and Drug-Induced Virus Self-Assembly Observed with Single-Particle Methods.

Authors:  Panagiotis Kondylis; Christopher J Schlicksup; Nicholas E Brunk; Jinsheng Zhou; Adam Zlotnick; Stephen C Jacobson
Journal:  J Am Chem Soc       Date:  2018-12-31       Impact factor: 15.419

Review 5.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

6.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 7.  Current advances in the elimination of hepatitis B in China by 2030.

Authors:  Shuye Zhang; Fusheng Wang; Zheng Zhang
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

Review 8.  The Structural Biology of Hepatitis B Virus: Form and Function.

Authors:  Balasubramanian Venkatakrishnan; Adam Zlotnick
Journal:  Annu Rev Virol       Date:  2016-08-01       Impact factor: 10.431

9.  Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.

Authors:  Shuo Wu; Qiong Zhao; Pinghu Zhang; John Kulp; Lydia Hu; Nicky Hwang; Jiming Zhang; Timothy M Block; Xiaodong Xu; Yanming Du; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 10.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.